Some 80 percent of U.S. vital medicines have precursors originating in China. And 20 percent of active pharmaceutical ingredients are solely sourced from China.
Flovent disappeared Jan. 1, when GSK pulled it. Insurers dropping coverage and Medicaid rule changes likely incentivized the move to protect profits.
Most of America’s generic drugs are produced in India and China, where the FDA has limited regulatory and oversight power. The Pentagon now wants to contract with a private firm for quality control.
Some 80 percent of U.S. vital medicines have precursors originating in China. And 20 percent of active pharmaceutical ingredients are solely sourced from China.
Flovent disappeared Jan. 1, when GSK pulled it. Insurers dropping coverage and Medicaid rule changes likely incentivized the move to protect profits.
Most of America’s generic drugs are produced in India and China, where the FDA has limited regulatory and oversight power. The Pentagon now wants to contract with a private firm for quality control.